Compagnie Lombard Odier SCmA Boosts Position in Solventum Co. (NYSE:SOLV)

Compagnie Lombard Odier SCmA increased its stake in Solventum Co. (NYSE:SOLV) by 98.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,015 shares of the company’s stock after buying an additional 1,000 shares during the period. Compagnie Lombard Odier SCmA’s holdings in Solventum were worth $133,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the stock. Modus Advisors LLC purchased a new position in Solventum during the 4th quarter valued at about $25,000. Copeland Capital Management LLC purchased a new position in Solventum during the 3rd quarter valued at about $26,000. Stonebridge Financial Group LLC purchased a new position in Solventum during the 4th quarter valued at about $26,000. Crews Bank & Trust purchased a new position in Solventum during the 4th quarter valued at about $32,000. Finally, True Wealth Design LLC increased its position in Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after purchasing an additional 471 shares during the period.

Wall Street Analysts Forecast Growth

A number of research firms have commented on SOLV. Mizuho began coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price on the stock. Morgan Stanley raised their target price on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Finally, Piper Sandler lifted their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Solventum currently has a consensus rating of “Hold” and an average target price of $68.29.

Solventum Price Performance

SOLV stock opened at $74.04 on Friday. The firm has a 50 day moving average of $70.67 and a 200 day moving average of $68.40. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.